In this study, we analyzed the cellular and molecular response of BCR-ABL- and JAK2V617F-expressing cells to IFNa, aiming to clarify the roles of STAT1 and STAT2 in IFNa monotherapy in CML and PV. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.